MedTrace Logo

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

NCT04943380 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 682

Last updated 2026-04-24

No results posted yet for this study

Summary

Prospective observational study to validate the performance characteristics and clinical utility of Cxbladder tests in a Veterans Affairs cohort.

Conditions

Interventions

DIAGNOSTIC_TEST

Cxbladder

The Cxbladder Detect+ test is a molecular diagnostic test. The test consists of six DNA biomarkers and five RNA biomarkers measured in a small volume of urine. is an enhanced version of the Cxbladder Detect test.

Sponsors & Collaborators

  • Pacific Edge Limited

    lead INDUSTRY

Principal Investigators

  • Tony Lough, PhD · Pacific Edge Pty Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-08
Primary Completion
2024-01-18
Completion
2024-01-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943380 on ClinicalTrials.gov